Trial of Rifaximin in the Treatment of Tropical Enteropathy

• Status: Completed
• Trial end date: 2007-10-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to determine whether rifaximin is effective in the treatment of tropical enteropathy in a population of African children at high risk for this disease.

• Phase: N/A
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Washington University School of Medicine
• Collaborators: Baylor College of Medicine; United States Department of Agriculture (USDA); University of Malawi College of Medicine
• Treatments: Rifamycins; Rifaximin

Criteria

Inclusion Criteria:

• live in single village

Exclusion Criteria:

• acutely malnourished

• acutely ill

• chronic disease